Detection of resting myocardial perfusion defects by SonoVue® myocardial contrast echocardiography

Echocardiography

Volumn 20, Issue 6, 2003, Pages 511-517

  Nahar, Tamanna ^a   Li, Peng ^a   Kuersten, Bettina ^a   Batra, Sanjay ^a   Vannan, Mani A ^a,b  

^a UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

^b DREXEL UNIVERSITY COLLEGE OF MEDICINE   (United States)

Author keywords

Myocardial contrast echocardiography; Myocardial perfusion; SonoVue

Indexed keywords

METHOXY ISOBUTYL ISONITRILE TECHNETIUM TC 99M; SONOVUE; SULFUR HEXAFLUORIDE;

ADULT; AGED; ARTICLE; B SCAN; CLINICAL ARTICLE; CONTRAST ECHOCARDIOGRAPHY; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DOPPLER ECHOCARDIOGRAPHY; DRUG SAFETY; FEMALE; HEART MUSCLE ISCHEMIA; HEART MUSCLE PERFUSION; HEART VENTRICLE WALL MOTION; HUMAN; MALE; MYOCARDIAL DISEASE; PRIORITY JOURNAL; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY;

AGED; CONTRAST MEDIA; ECHOCARDIOGRAPHY; ECHOCARDIOGRAPHY, DOPPLER; FEMALE; HEART; HUMANS; MALE; MICROBUBBLES; MYOCARDIAL ISCHEMIA; PHOSPHOLIPIDS; RADIOPHARMACEUTICALS; SULFUR HEXAFLUORIDE; TECHNETIUM TC 99M SESTAMIBI; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

EID: 0042164782     PISSN: 07422822     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1540-8175.2003.03087.x     Document Type: Article

References (11)

1. Kaul S, Senior R, Dittrich H, et al: Detection of coronary artery disease with myocardial contrast echocardiography: Comparison with 99mTc-sestamibi single-photon emission computed tomography. Circulation 1997;96:785-792.
2. Kaps M, Seidel G, Bokor D, et al: Safety and ultrasound enhancing potentials of a new sulfur hexafluoride-containing agent in the cerebral circulation. J Neuroimaging 1999;9:150-154.
3. Broillet A, Puginier J, Ventrone R, et al: Assessment of myocardial perfusion by intermittent harmonic power Doppler using SonoVue, a new ultrasound contrast agent. Invest Radiol 1998;33:209-215.
4. Rovai D, Lubrano V, Vassalle C, et al: Detection of perfusion defects during coronary occlusion and myocardial reperfusion after thrombolysis by intravenous administration of the echo-enhancing agent BR1. J Amer Soc Echocardiogr 1998;11:169-180.
5. Schneider M, Broillet A, Arditi M, et al: Doppler intensometry with BR1, a sonographic contrast agent. Acad Radiol 1996;3:S308-S311.
6. Schneider M, Arditi M, Barrau M-B, et al: BR1: A new ultrasonographic contrast agent based on sulfur hexafluoride-filled microbubbles. Invest Radiol 1995;30:451-457.
7. Vannan MA, Kuersten B: Imaging techniques for myocardial contrast echocardiography. Eur J Echocardiogr 2000;1:224-226.
8. Wei K, Jayaweera AR, Firoozan S, et al: Quantification of myocardial blood flow with ultrasound-induced destruction of microbubbles administered as a constant venous infusion. Circulation 1998;97:473-483.
9. Lindner JR, Villanueva FS, Dent JM, et al: Assessment of resting perfusion with myocardial contrast echocardiography: Theoretical and practical considerations. Am Heart J 2000;139:231-240.
10. Lindner JR, Wei K, Kaul S: Imaging of myocardial perfusion with SonoVue in patients with a prior myocardial infarction. Echocardiography 1999;16(Part 2):753-760.
11. 99mTc-Sestamibi SPECT imaging. Circulation 2000;102:55-60.